Abstract Background In 2007, Alberta became the first Canadian jurisdiction to grant
pharmacists a wide range of prescribing privileges. Our objective was to understand what …

BACKGROUND: More than 90 medicines in the United Kingdom alone have been
reclassified from “prescription only” to “pharmacy” availability, and many of these have …

Objectives: To explore the implementation of patient oriented activities, the perception of an
innovation aimed at implementation of patient education and the preconditions for …

Background The successful diffusion of new drugs is crucial for both pharmaceutical
companies and patients—and of wider stakeholder concern, including for the funding of …

Objective To examine the views of regular pharmacy clients on pharmacist prescribing and
employ agency theory in considering the relationship between the stakeholders involved …

The drug product life cycle is affected by factors that influence the diffusion of a new drug
into medical practice and its rate of adoption and relinquishment by individual physicians …

Objective: To explore what is known about organizational processes that determine whether
(and the extent and rate at which) new non-pharmaceutical technologies are adopted and …

Background: Vision and action plans have been created to address the future of pharmacy
and help pharmacists progress into expanded roles in order to provide more patient-centred …

Objectives To evaluate the views of Australian pharmacists on expanded pharmacist
prescribing roles and identify important drivers and barriers to its implementation. Setting …

The broad purposes of pharmacoepidemiology are to advance our knowledge of the risks
and benefits of medication use in real-world populations, and to foster improved prescribing …